Amundi’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-23,875
Closed -$389K 2160
2026
Q1
$389K Sell
23,875
-116,242
-83% -$1.82M ﹤0.01% 1645
2025
Q4
$2.08M Buy
140,117
+58,358
+71% +$825K ﹤0.01% 1159
2025
Q3
$1.06M Buy
81,759
+64,401
+371% +$858K ﹤0.01% 1144
2025
Q2
$263K Sell
17,358
-24,222
-58% -$378K ﹤0.01% 1549
2025
Q1
$673K Sell
41,580
-11,032
-21% -$203K ﹤0.01% 1429
2024
Q4
$985K Buy
52,612
+18,200
+53% +$351K ﹤0.01% 1409
2024
Q3
$619K Buy
34,412
+3,341
+11% +$64K ﹤0.01% 1389
2024
Q2
$608K Sell
31,071
-3,562
-10% -$60.8K ﹤0.01% 1311
2024
Q1
$493K Buy
34,633
+9,319
+37% +$136K ﹤0.01% 1433
2023
Q4
$358K Buy
25,314
+1,292
+5% +$16.3K ﹤0.01% 1498
2023
Q3
$300K Sell
24,022
-550
-2% -$8.49K ﹤0.01% 1505
2023
Q2
$412K Sell
24,572
-2,310
-9% -$35.8K ﹤0.01% 1426
2023
Q1
$391K Buy
+26,882
New +$396K ﹤0.01% 1404
2022
Q4
Sell
-1,459
Closed -$17K 1971
2022
Q3
$17K Sell
1,459
-1,347
-48% -$19.1K ﹤0.01% 1759
2022
Q2
$36K Sell
2,806
-446
-14% -$5.72K ﹤0.01% 1564
2022
Q1
$42K Sell
3,252
-205,071
-98% -$2.71M ﹤0.01% 1550
2021
Q4
$3.3M Buy
+208,323
New +$3.56M ﹤0.01% 1107
2021
Q3
Sell
-111,037
Closed -$2.53M 1632
2021
Q2
$2.53M Buy
+111,037
New +$2.3M ﹤0.01% 1121

Other funds holding SEM

Amundi's SEM Position: Q2 2026 in Review

Amundi sold out of Select Medical (SEM) in Q2 2026, closing a stake of 23,875 shares — an estimated $389K sold.

Amundi first reported a position in SEM in Q2 2021 and held it in 18 quarters. The position peaked at $3.3M in Q4 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Amundi reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
  • Amundi sold 23,875 Select Medical shares in Q2 2026, an estimated $389K.
  • Amundi first reported a position in Select Medical in Q2 2021 and held it in 18 quarters.
  • Amundi's Select Medical position peaked at $3.3M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.